Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioChip Labs offers CLIA-certified laboratory testing specializing in blood disorders such as sickle cell disease and thalassemia. The company is developing a proprietary microfluidic device ("Endothelium-on-a-chip") with machine learning automation to enable efficient drug screening and a nanoparticle-based system to simplify the manufacturing of biologics by directly purifying monoclonal antibodies from cell culture. Their technology aims to reduce costs, improve yields, and enable mass commercialization of advanced therapies like gene therapy[1][2][3][5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioChip Labs.